Welcome to LookChem.com Sign In|Join Free

CAS

  • or

842136-59-8

Post Buying Request

842136-59-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

842136-59-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 842136-59-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,2,1,3 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 842136-59:
(8*8)+(7*4)+(6*2)+(5*1)+(4*3)+(3*6)+(2*5)+(1*9)=158
158 % 10 = 8
So 842136-59-8 is a valid CAS Registry Number.

842136-59-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-2-chloro-N-methoxy-N-methylbenzamide

1.2 Other means of identification

Product number -
Other names 5-bromo-2-chloro-N-methoxy-N-methyl-benzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:842136-59-8 SDS

842136-59-8Downstream Products

842136-59-8Relevant articles and documents

SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS

-

Page/Page column 45, (2019/08/08)

The present invention relates to substituted alkynylene compounds represented by compound of formula (I) pharmaceutically acceptable salts and stereoisomers thereof. The present invention further provides the methods of preparation of compound of formula (I) and therapeutic uses thereof as anti-cancer agents.

NOVEL PROCESSES FOR PREPARATION OF DAPAGLIFLOZIN OR ITS SOLVATES OR CO-CRYSTALS THEREOF

-

Page/Page column 60, (2018/03/06)

The present invention generally relates to an improved process for the preparation of dapagliflozin of Formula I or its solvates or co-crystals thereof. The present invention also encompasses the novel intermediates and their use in the preparation of dap

HEPATITIS B ANTIVIRAL AGENTS

-

Paragraph 0171, (2017/02/24)

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: [in-line-formulae]X-A1-Y-A2-Z-L-R??(I)[/in-line-formulae] which inhibit the protein(s) encoded by hepatitis

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 842136-59-8